Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd. Statistics
Share Statistics
Alpha Tau Medical Ltd. has 69.92M shares outstanding. The number of shares has increased by 0.84% in one year.
Shares Outstanding | 69.92M |
Shares Change (YoY) | 0.84% |
Shares Change (QoQ) | 0.65% |
Owned by Institutions (%) | 1.4% |
Shares Floating | 51.99M |
Failed to Deliver (FTD) Shares | 768 |
FTD / Avg. Volume | 0.83% |
Short Selling Information
The latest short interest is 67.06K, so 0.1% of the outstanding shares have been sold short.
Short Interest | 67.06K |
Short % of Shares Out | 0.1% |
Short % of Float | 0.13% |
Short Ratio (days to cover) | 3.01 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -8.27. Alpha Tau Medical Ltd.'s PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -8.27 |
PS Ratio | 0 |
Forward PS | 0.7 |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Alpha Tau Medical Ltd..
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.4, with a Debt / Equity ratio of 0.2.
Current Ratio | 7.4 |
Quick Ratio | 7.4 |
Debt / Equity | 0.2 |
Debt / EBITDA | -0.45 |
Debt / FCF | -0.57 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-233.26K |
Employee Count | 125 |
Asset Turnover | null |
Inventory Turnover | n/a |
Taxes
Income Tax | 16K |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -12.07% in the last 52 weeks. The beta is 0.87, so Alpha Tau Medical Ltd.'s price volatility has been higher than the market average.
Beta | 0.87 |
52-Week Price Change | -12.07% |
50-Day Moving Average | 3 |
200-Day Moving Average | 2.61 |
Relative Strength Index (RSI) | 41.41 |
Average Volume (20 Days) | 92.52K |
Income Statement
Revenue | n/a |
Gross Profit | -1.07M |
Operating Income | 35.68M |
Net Income | -29.16M |
EBITDA | -28.03M |
EBIT | -29.1M |
Earnings Per Share (EPS) | -0.42 |
Balance Sheet
The company has 13.72M in cash and 12.54M in debt, giving a net cash position of 1.19M.
Cash & Cash Equivalents | 13.72M |
Total Debt | 12.54M |
Net Cash | 1.19M |
Retained Earnings | -147.51M |
Total Assets | 86.2M |
Working Capital | 55.55M |
Cash Flow
In the last 12 months, operating cash flow was -19.78M and capital expenditures -2.24M, giving a free cash flow of -22.02M.
Operating Cash Flow | -19.78M |
Capital Expenditures | -2.24M |
Free Cash Flow | -22.02M |
FCF Per Share | 0 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for DRTS is $8, which is 213.7% higher than the current price. The consensus rating is "Buy".
Price Target | $8 |
Price Target Difference | 213.7% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | 1.48 |
Piotroski F-Score | 2 |